SGLT2 Inhibitors in the Treatment of Diabetic Kidney Disease: More than Just Glucose Regulation

Diabetic kidney disease (DKD) is a severe and common complication and affects a quarter of patients with type 2 diabetes mellitus (T2DM). Oxidative stress and inflammation related to hyperglycemia are interlinked and contribute to the occurrence of DKD. It was shown that sodium–glucose cotransporter...

Descripción completa

Detalles Bibliográficos
Autores principales: Klen, Jasna, Dolžan, Vita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10386344/
https://www.ncbi.nlm.nih.gov/pubmed/37514181
http://dx.doi.org/10.3390/pharmaceutics15071995

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10386344/
https://www.ncbi.nlm.nih.gov/pubmed/37514181
http://dx.doi.org/10.3390/pharmaceutics15071995

Ejemplares similares